[1] |
王祥慧.2013肾脏移植国际前沿热点及新进展——What's Hot? What's New?[J/CD].实用器官移植电子杂志, 2013, 1(4): 203-204.WANG XH. International frontier hot spots and new progress on renal transplantation in 2013: What's Hot? What's New?[J/CD]. Pract J Organ Transplant (Electr Vers), 2013, 1(4): 203-204.
|
[2] |
范宇, 石炳毅, 钱叶勇, 等.肾移植术后BK病毒感染对移植肾功能影响的临床研究[J].器官移植, 2018, 9(1):51-57. DOI: 10.3969/j.issn.1674-7445.2018.01.007.FAN Y, SHI BY, QIAN YY, et al. Clinical study on the effect of BK virus infection on renal allograft function after renal transplantation[J]. Organ Transplant, 2018, 9(1):51-57. DOI: 10.3969/j.issn.1674-7445.2018.01.007.
|
[3] |
NETO MM, COSTA RS, FREZZA G, et al. Cytomegalovirus-associated glomerulonephritis in a kidney transplant recipient[J]. Prog Transplant, 2018, 28(4):398-399. DOI: 10.1177/1526924818800034.
|
[4] |
LEE H, PARK KH, RYU JH, et al. Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients[J]. PLoS One, 2017, 12(12):e0189488. DOI: 10.1371/journal.pone.0189488.
|
[5] |
乔良伟, 曲青山, 苗书斋.肾移植术后巨细胞病毒肺炎患者发生急性呼吸窘迫综合征的危险因素探讨[J].中华医院感染学杂志, 2013, 23(13):3146-3148. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyygrxzz201313043QIAO LW, QU QS, MIAO SZ. Risk factors of cytomegalovirus pneumonia in patients with acute respiratory distress syndrome after renal transplantation[J]. Chin J Nosocom, 2013, 23(13):3146-3148. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyygrxzz201313043
|
[6] |
REUSING JO JR, FEITOSA EB, AGENA F, et al. Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: outcome and risk factors for late CMV disease[J]. Transpl Infect Dis, 2018, 20(5):e12929. DOI: 10.1111/tid.12929.
|
[7] |
KIM SH, LEE HJ, KIM SM, et al. Diagnostic usefulness of cytomegalovirus (CMV)-specific T cell immunity in predicting CMV infection after kidney transplantation: a pilot proof-of-concept study[J]. Infect Chemother, 2015, 47(2):105-110. DOI: 10.3947/ic.2015.47.2.105.
|
[8] |
金春明.肾移植后巨细胞病毒感染的检测[J].中国组织工程研究, 2012, 16(40):7572-7579. DOI: 10.3969/j.issn.2095-4344.2012.40.029.JIN CM. Detection of cytomegalovirus infection after renal transplantation[J]. Chin J Tissue Eng Res, 2012, 16(40):7572-7579. DOI: 10.3969/j.issn.2095-4344.2012. 40.029.
|
[9] |
LENAC ROVIS T, KUCAN BRLIC P, KAYNAN N, et al. Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection[J]. J Exp Med, 2016, 213(9):1835-1850. DOI: 10.1084/jem.20151899.
|
[10] |
NABEKURA T, KANAYA M, SHIBUYA A, et al. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection[J]. Immunity, 2014, 40(2):225-234. DOI: 10.1016/j.immuni.2013.12.011.
|
[11] |
KOTTON CN, KUMAR D, CALIENDO AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation[J]. Transplantation, 2018, 102(6):900-931. DOI: 10.1097/TP.0000000000002191.
|
[12] |
杨春媚, 张婷婷, 钱程, 等. NK细胞抗肿瘤机制及相关免疫疗法的研究进展[J].中国药理学通报, 2019, 35(11):1492-1496. DOI: 10.3969/j.issn.1001-1978.2019. 11.003.YANG CM, ZHANG TT, QIAN C, et al. Progress in research on anti-tumor mechanism of NK cell and its related immunotherapy[J]. Chin Pharmacol Bull, 2019, 35(11):1492-1496. DOI: 10.3969/j.issn.1001-1978. 2019.11.003.
|
[13] |
BARRY KC, HSU J, BROZ ML, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments[J]. Nat Med, 2018, 24(8):1178-1191. DOI: 10.1038/s41591-018-0085-8.
|
[14] |
刘志佳, 于涛, 孙曙, 等.巨细胞病毒感染下调肾移植受者NK细胞CD226和CD16的表达[J].细胞与分子免疫学杂志, 2015, 31(10):1391-1395. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xbyfzmyxzz201510022LIU ZJ, YU T, SUN S, et al. Cytomegalovirus infection down-regulates the expressions of CD226 and CD16 in blood NK cells of the renal transplant recipient[J]. Chin J Cell Mol Immunol, 2015, 31(10):1391-1395. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xbyfzmyxzz201510022
|
[15] |
DRICK N, SEELIGER B, GREER M, et al. DNA-based testing in lung transplant recipients with suspected non-viral lower respiratory tract infection: a prospective observational study[J]. Transpl Infect Dis, 2018, 20(1): e12811. DOI: 10.1111/tid.12811.
|
[16] |
SARMIENTO E, CIFRIAN J, CALAHORRA L, et al. Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: a multicenter prospective study[J]. J Heart Lung Transplant, 2018, 37(8):1001-1012. DOI: 10.1016/j.healun. 2018.04.001.
|
[17] |
KHVEDELIDZE M, CHKHARTISHVILI N, ABASHIDZE L, et al. Expansion of CD3/CD16/CD56 positive NKT cells in HIV/AIDS: the pilot study[J]. Georgian Med News, 2008(165):78-83. http://europepmc.org/abstract/MED/19124922
|
[18] |
JIANG Y, CUI X, CUI C, et al. The function of CD3+CD56+ NKT-like cells in HIV-infected individuals[J]. Biomed Res Int, 2014:863625. DOI: 10.1155/2014/863625.
|
[19] |
TAURIAINEN J, SCHARF L, FREDERIKSEN J, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals[J]. Sci Rep, 2017, 7:40354. DOI: 10.1038/srep40354.
|
[20] |
MATUSALI G, POTESTÀ M, SANTONI A, et al. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR[J]. J Virol, 2012, 86(8):4496-4504. DOI: 10.1128/JVI.05788-11.
|
[21] |
LOZANO E, DOMINGUEZ-VILLAR M, KUCHROO V, et al. The TIGIT/CD226 axis regulates human T cell function[J]. J Immunol, 2012, 188(8):3869-3875. DOI: 10.4049/jimmunol.1103627.
|
[22] |
BRUEL T, GUIVEL-BENHASSINE F, AMRAOUI S, et al. Elimination of HIV-1-infected cells by broadly neutralizing antibodies[J]. Nat Commun, 2016, 7:10844. DOI: 10.1038/ncomms10844.
|
[23] |
MIKULAK J, ORIOLO F, ZAGHI E, et al. Natural killer cells in HIV-1 infection and therapy[J].AIDS, 2017, 31(17):2317-2330. DOI: 10.1097/QAD. 0000000000001645.
|
[24] |
BERNARD NF, KIANI Z, TREMBLAY-MCLEAN A, et al. Natural killer (NK) cell education differentially influences HIV antibody-dependent NK cell activation and antibody-dependent cellular cytotoxicity[J]. Front Immunol, 2017, 8:1033. DOI: 10.3389/fimmu. 2017.01033.
|
[25] |
FLÓREZ-ÁLVAREZ L, HERNANDEZ JC, ZAPATA W. NK Cells in HIV-1 infection: from basic science to vaccine strategies[J]. Front Immunol, 2018, 9:2290. DOI: 10.3389/fimmu.2018.02290.
|